Does TOLVAPTAN Cause Product dose omission issue? 379 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 379 reports of Product dose omission issue have been filed in association with TOLVAPTAN (Jynarque). This represents 4.2% of all adverse event reports for TOLVAPTAN.
379
Reports of Product dose omission issue with TOLVAPTAN
4.2%
of all TOLVAPTAN reports
11
Deaths
70
Hospitalizations
How Dangerous Is Product dose omission issue From TOLVAPTAN?
Of the 379 reports, 11 (2.9%) resulted in death, 70 (18.5%) required hospitalization, and 3 (0.8%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOLVAPTAN. However, 379 reports have been filed with the FAERS database.
What Other Side Effects Does TOLVAPTAN Cause?
Death (800)
Thirst (624)
Off label use (560)
Renal impairment (534)
Underdose (448)
Product use in unapproved indication (446)
Wrong technique in product usage process (426)
Polyuria (390)
Inappropriate schedule of product administration (376)
Blood creatinine increased (337)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which TOLVAPTAN Alternatives Have Lower Product dose omission issue Risk?
TOLVAPTAN vs TOPAMAX
TOLVAPTAN vs TOPIRAMATE
TOLVAPTAN vs TOPOTECAN
TOLVAPTAN vs TOPOTECAN\TOPOTECAN
TOLVAPTAN vs TOPROL